Xuefeng F. Wang
Expertise in
15
conditions

Xuefeng F. Wang

No.197 Ruijin Second Road, 
Shanghai, CN 
Expertise in
15
conditions
No.197 Ruijin Second Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Xuefeng Wang practices in Shanghai, China. Wang is highly rated in 15 conditions, according to our data. Their top areas of expertise are Dysfibrinogenemia, Blood Clots, Factor 10 Deficiency, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Their clinical research consists of co-authoring 152 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

No.197 Ruijin Second Road, Shanghai, 200025, China
Other Locations
1665 Kongjiang Road, Shanghai, 200092, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Long Term Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Cholecystectomy for Choledocholithiasis: a Multicenter Prospected Non-randomized Controlled Study
A Long Term Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Cholecystectomy for Choledocholithiasis: a Multicenter Prospected Non-randomized Controlled Study
Enrollment Status: Completed
Publish Date: January 05, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Effect of Different Endoscopic Papillary Balloon Dilation Duration Time on Complications of Common Bile Duct Stone Patient
Effect of Different Endoscopic Papillary Balloon Dilation Duration Time on Complications of Common Bile Duct Stone Patient
Enrollment Status: Completed
Publish Date: January 25, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

152 Total Publications

Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity.
Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity.
Journal: Thrombosis and haemostasis
Published: December 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile